Adipose-Derived Stem Cells in Bone Tissue Engineering: Useful Tools with New Applications

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Cell Biology

Background:

• Adipose stem cells (ASCs) are a promising alternative to bone marrow mesenchymal stem cells (MSCs) for bone tissue engineering (BTE).
• ASCs possess advantageous proliferative, differentiative, and paracrine activities, including the secretion of bioactive molecules via exosomes.
• BTE traditionally relies on scaffolds, osteoprogenitor cells, and bioactive factors, all areas where ASCs offer significant advancements.

Purpose of the Study:

• To review recent discoveries concerning the application of ASCs in bone tissue engineering.
• To analyze ASC subpopulations with enhanced osteogenic and vasculogenic capacities.
• To examine the interplay between ASCs and scaffolds, and the role of ASC-secreted bioactive factors and exosomes in bone regeneration.

Main Methods:

• Phenotypic study of ASC subpopulations.
• Investigation of ASC-scaffold interactions.
• Analysis of bioactive factors and exosomes secreted by ASCs.
• Review of literature on ASCs in BTE.

Main Results:

• ASCs facilitate improved scaffold vascularization and integration.
• Specific ASC subpopulations exhibit enhanced osteogenic and vasculogenic potential.
• ASC-derived exosomes mediate significant paracrine effects, recruiting progenitor cells and promoting regeneration.
• ASCs reduce the need for external bioactive factors due to their inherent osteogenic properties.

Conclusions:

• ASCs represent a key cell source for advancing bone tissue engineering.
• The unique properties of ASCs and their secreted exosomes offer novel therapeutic strategies for bone regeneration.
• Further research into ASC subpopulations and their interactions holds promise for faster clinical translation of BTE therapies.